ANAL CARCINOMA
Clinical trials for ANAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early cancer drug trial halted after initial safety testing
Disease control TerminatedThis early-stage study tested a new drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety, how the body processes it, and what side effects it might cause. The trial was termina…
Matched conditions: ANAL CARCINOMA
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope: testing powerful cancer drugs for people with HIV
Disease control TerminatedThis early-stage study tested the safety and best dose of two immunotherapy drugs, nivolumab and ipilimumab, for people living with HIV who also have advanced cancers like Hodgkin lymphoma, Kaposi sarcoma, or lung cancer. The goal was to see if these drugs, which help the immune …
Matched conditions: ANAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC